Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS)
Status:
Enrolling by invitation
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this prospective controlled study is to obtain a multi-center safety and
feasibility data on patients managed with anti-thrombotic monotherapy with HeartMate 3 LVAS.